Oncology and Hematology

Oncology and Hematology Clinical Practice

Stay current with Oncology and Hematology education that fits how you practice. ReachMD offers practical, on-demand clinical content for oncologists, hematologists, oncology nurses, pharmacists, fellows, APPs, and the full cancer care team. Explore expert discussions, case-based programs, CME/CE opportunities, industry features, and news across solid tumors, hematologic malignancies, biomarker-driven care, immunotherapy, targeted therapy, supportive care, and more.

Use this page to find relevant oncology and hematology content fast. Browse Project Oncology episodes, jump into CME/CE activities, review expert perspectives, or explore timely updates on evolving treatment strategies and standards of care. New content is added regularly, so you can stay current with emerging evidence, guideline updates, and multidisciplinary approaches to cancer care on your schedule.

Start with the latest programs below or browse by content type to find the Oncology and Hematology education most relevant to your practice.

993

LikeLikedUnlike

331-339 of 339

TROP2-Directed ADCs in Lung Cancer
MinuteCE®
TROP2-Directed ADCs in Lung Cancer
- Justin Gainor, MD
TROP2-Directed ADCs in Bladder Cancer
MinuteCE®
TROP2-Directed ADCs in Bladder Cancer
- Gopa Iyer, MD
HER2-Directed ADCs in Gastric Cancer
MinuteCE®
HER2-Directed ADCs in Gastric Cancer
- Jaffer Ajani, MD
MinuteCE®
A Deep Dive into the Management of AEs Associated with ADCs
- Jaffer Ajani, MD
- Justin Gainor, MD
- Sara A. Hurvitz, MD, FACP
- Gopa Iyer, MD
HER3-Directed ADCs in Breast Cancer
MinuteCE®
HER3-Directed ADCs in Breast Cancer
- Sara A. Hurvitz, MD, FACP
A Novel Therapeutic Approach in Myeloid Malignancies: Targeting the Neddylation Pathway
CME/CE
A Novel Therapeutic Approach in Myeloid Malignancies: Targeting the Neddylation Pathway
- Jennifer Caudle, DO, FACOFP
- Mikkael A. Sekeres, MD, MS
- Sara M. Tinsley, PhD, ARNP, AOCNP
0.50 credits
advertisement
Unresectable HCC: An Emerging Era of Combination Therapy – A Clinical Convergence^®
CME/CE
Unresectable HCC: An Emerging Era of Combination Therapy – A Clinical Convergence^®
- Richard S. Finn, MD
- Amit Singal, MD, MS
- Mark Yarchoan, MD
Insights from the Latest Clinical Trials in Lung Cancer
CME/CE
Insights from the Latest Clinical Trials in Lung Cancer
- Mark Socinski, MD
- Tarek M. Mekhail, MD, MSC, FRCSI, FRCSEd
0.25 credits
Immunotherapy: Changing Patient Outcomes in SCLC
CME/CE
Immunotherapy: Changing Patient Outcomes in SCLC
- Leora Horn, MD, MSc